This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

NBT-PABA

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The NBT-PABA test is the most widely used test of pancreatic exocrine insufficiency in the UK with a specificity of 95% and a sensitivity of 80-90%.

NBT-PABA is hydrolysed by pancreatic chymotrypsin to PABA which is then is absorbed and excreted in the urine. To control for variation in PABA absorption a trace quantity of C14-labelled PABA is given with the bulk unlabelled NBT-PABA.


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.